Page 20 - Technical Operations News Today

Dosing of patients in Phase 3 AFFINE trial to support primary analysis complete; pivotal data read-out expected in mid-2024; BLA and MAA submissions anticipated in second half of 2024. ... | April 26, 2023

Maintenance and Safety Data Improve Predictability of Airline OperationsRaytheon Technologies’ Collins Aerospace business has partnered with American

Strong clinical momentum continues in Phase 1/2 STAAR study in Fabry disease with 20 patients dosed in total. Dosed third patient in cohort 1 of Phase 1/2 CAR-Treg STEADFAST study for TX200 in... | June 18, 2023

25 April 2023 By Tom Collins tom@TheCork.ie Increases the Company’s Capacity to Supply Medicines Globally In recent days the global biopharmaceutical company BioMarin Pharmaceutical Inc. opened the expansion of its manufacturing plant at Shanbally, Co. Cork. The company has invested €38 million over four years to create a state-of-the-art aseptic production facility. The new facility…

Third Generation Steps in to Lead New Era of Accelerated Sales Growth and Continued Technology InnovationSYRACUSE, NY / ACCESSWIRE / April 25, 202...

In newly published analysis, Kite's CAR T-cell therapy delivered a reduced median European manufacturing turnaround time for DLBCL patients.

BioMarin Pharmaceutical has opened the expansion of its manufacturing plant at Shanbally, Co. Cork: with the site now able to provide end-to-end manufacturing for a number of the company’s commercial products.

Versie 23.04 van Linuxdistributie Ubuntu is uitgekomen, een versie die negen maanden ondersteuning krijgt. Tweemaal per jaar verschijnt er een nieuwe versie en vormen het jaar en de maand van uitgave het versienummer.

He company has invested €38 million over four years to create a state-of-the-art aseptic production facility that will manufacture, package and label ...

BioMarin invested the money over a four-year period in its Irish operations. Its Cork manufacturing plant is its largest outside of the US.